We are conducting routine maintenance on portfolio manager. We'll be back up as soon as possible. Thanks for your patience.

10 Most Popular Funds in March 2017 (Taiwan Domiciled)

10 Most Searched for Taiwan Domiciled Funds by tw.morningstar.com users

Morningstar Editors 14 April, 2017 | 10:21
Facebook Twitter LinkedIn

 

1. ABITL Global High Yield Fund TA RMB
Morningstar Category: High Yield Bond - Other Hedged
Morningstar Rating (2017-03-31): Not Rated

2. Taishin High Dividend Yield Balanced Fund
Morningstar Category: TWD Moderate Allocation
Morningstar Rating (2017-03-31): Stars 5

3. Allianz Global Investors Target Income Fund B TWD
Morningstar Category: High Yield Bond - Other Hedged
Morningstar Rating (2017-03-31):Not Rated

4. ABITL Global High Yield Fund TA TWD
Morningstar Category: High Yield Bond - Other Hedged
Morningstar Rating (2017-03-31): Not Rated

5. UBS (TW) Bond Fund - Asian High Yield - B
Morningstar Category: Asia High Yield Bond
Morningstar Rating (2017-03-31): Stars 3

6. Yuanta Global ETFs Stable Fund of Funds
Morningstar Category: Global Large-Cap Blend Equity
Morningstar Rating(2017-03-31): Stars 4

7. Allianz Global Investors Taiwan Fund
Morningstar Category: Taiwan Small/Mid-Cap Equity
Morningstar Rating (2017-03-31): Stars 5

8. PineBridge Global Multi-Strategy High Yield Bond Fund B TWD
Morningstar Category: Global High Yield Bond
Morningstar Rating (2017-03-31): Stars 2

9. SinoPac CSI 300 Dividend Index Fund
Morningstar Category: China Equity - A Shares
Morningstar Rating (2017-03-31): Stars 4

10. Allianz Global Investors Global Biotech Fund TWD
Morningstar Category: Sector Equity Biotechnology
Morningstar Rating (2017-03-31): Stars 3

 

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

 

Facebook Twitter LinkedIn

About Author

Morningstar Editors  -

© Copyright 2024 Morningstar Asia Ltd. All rights reserved.

Terms of Use        Privacy Policy         Disclosures